Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB: OTLC), a clinical-stage biotechnology company focused on oncology and AI-driven solutions, today provided an update on the continued ...

A premapped course, a crew of handlers and a world-beating time: here’s what this Beijing half marathon reveals about how far ...

In 2026, AI is increasingly entering the physical world. Rather than being confined to software and apps running on our computers and phones, it will share our lives with us in the form of physical ...

Apptronik CEO Jeff Cardenas is stacking the company with humanoid robotics veterans from key companies. Apptronik, the Austin ...

Gabriel Gomes believes the future of chemistry is as much about flasks and fume hoods as it is about code. A chemical engineer at Carnegie Mellon University, Gomes works at the intersection of ...

This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American Imagine if the entire population of Oakland, ...

This striking humanoid robot is the R1 from Robbyant, a company owned by Chinese tech giant Ant Group. The allure of humanoid robots is their versatility – you can imagine them doing any job that a ...

We talk to Stefan Leutenegger, professor at ETH Zurich, about humanoids' transition from gimmick to core hospitality ...